| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-12T02:50:39Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; CHAO-CHI HO; Liang S.-K.;Lee M.-R.;Liao W.-Y.;Chao-Chi Ho;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y. |
| 臺大學術典藏 |
2021-03-11T08:29:34Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T02:50:57Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
SHENG-KAI LIANG; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-10-04T07:15:41Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liao W.-Y.; MENG-RUI LEE; Liang S.-K.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 國立臺灣大學 |
2006 |
Prognostic Factors of Anaplastic Thyroid Carcinoma
|
曾芬郁; TSENG, FEN-YU |
| 臺大學術典藏 |
2013-10 |
Prognostic Factors of Bile Duct Cancers in Patients Receiving Pretreatment FDG PET/CT.
|
RUOH-FANG YEN; RUOH-FANG YEN |
| 中國醫藥大學 |
2003-08-30 |
Prognostic Factors of Biochemical Failure after Radical Prostatectomy.
|
謝登富(DENG-FU HSIEH); 吳錫金(Wu,His-Chin); 張兆祥(Chang,Chao-Hsian); 陳汶吉(Chen,Wen-Chi); 陳昶仲(Chang-Chung Chen); 鄒頡龍; 陳國樑 |
| 淡江大學 |
2023-10-27 |
Prognostic Factors of Cirrhotic Patients with Invasive Fungal Infections
|
Hung, Tsung-Hsing;Ko, Ping-Hung;Tsai, Chih-Chun;Wang, Chih-Ying;Lee, Hsing-Feng |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
WEN-FANG CHENG;Twu N.-F.;Hsu H.-C.;Wu H.-H.;Lau H.-Y.;Hsieh S.-F.; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:49:34Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
Hsieh S.-F.;Lau H.-Y.;Wu H.-H.;Hsu H.-C.;Twu N.-F.;Wen-Fang Cheng; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2021-09-27T06:18:42Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; HENG-CHENG HSU; Twu N.-F.; Cheng W.-F. |
| 臺大學術典藏 |
2021-03-10T02:34:33Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
Hsieh S.-F.;Lau H.-Y.;Wu H.-H.;Heng-Cheng Hsu;Twu N.-F.;Cheng W.-F.; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; HENG-CHENG HSU; Twu N.-F.; Cheng W.-F. |
| 臺大學術典藏 |
2021-08-15T00:08:08Z |
Prognostic factors of functional outcome in post-acute stroke in the rehabilitation unit
|
Chen, Wei Chieh; MING-YEN HSIAO; TYNG-GUEY WANG |
| 臺大學術典藏 |
2021-09-28T06:34:44Z |
Prognostic factors of functional outcome in post-acute stroke in the rehabilitation unit
|
WEI-CHIEH CHEN; MING-YEN HSIAO; TYNG-GUEY WANG |
| 臺大學術典藏 |
2021-10-28T08:06:20Z |
Prognostic factors of functional outcome in post-acute stroke in the rehabilitation unit
|
Chen, Wei-Chieh; MING-YEN HSIAO; Wang, Tyng-Guey |
| 臺大學術典藏 |
2022-01-14T05:53:24Z |
Prognostic factors of functional outcome in post-acute stroke in the rehabilitation unit
|
Chen W.-C.; Hsiao M.-Y.; TYNG-GUEY WANG |
| 臺大學術典藏 |
2019-10-09T07:12:27Z |
Prognostic factors of health care-associated bloodstream infection in adult patients ≥40 years of age
|
YEE-CHUN CHEN;JEN-PEI LIU;WEI-CHU CHIE;JANN-TAY WANG;WANG-HUEI SHENG;Chang, Ying-Ying;Huang, Ya-Huei;Hung, I-Chen;Ma, Hsuan-Yin; Ma, Hsuan-Yin; Hung, I-Chen; Huang, Ya-Huei; Chang, Ying-Ying; WANG-HUEI SHENG; JANN-TAY WANG; WEI-CHU CHIE; JEN-PEI LIU; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-09-29T01:47:34Z |
Prognostic factors of health care-Vassociated bloodstream infection in adult patients ≥ 40 years of age
|
Wang J.-T.; Chang Y.-Y.; Sheng W.-H.; Ma H.-Y.; Hung I.-C.; Huang Y.-H.; Chie W.-C.; Liu J.-P.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-12-29T03:08:43Z |
Prognostic factors of health care–associated bloodstream infection in adult patients ?40 years of age
|
Ma H.-Y.;Hung I.-C.;Huang Y.-H.;Chang Y.-Y.;Sheng W.-H.;Jann-Tay Wang;Chie W.-C.;Liu J.-P.;Chen Y.-C.; Ma H.-Y.; Hung I.-C.; Huang Y.-H.; Chang Y.-Y.; Sheng W.-H.; JANN-TAY WANG; Chie W.-C.; Liu J.-P.; Chen Y.-C. |
| 臺大學術典藏 |
2021-02-26T01:59:26Z |
Prognostic factors of health care–associated bloodstream infection in adult patients ?40 years of age
|
Ma H.-Y.;Hung I.-C.;Huang Y.-H.;Chang Y.-Y.;Wang-Huei Sheng;Wang J.-T.;Chie W.-C.;Liu J.-P.;Chen Y.-C.; Ma H.-Y.; Hung I.-C.; Huang Y.-H.; Chang Y.-Y.; WANG-HUEI SHENG; Wang J.-T.; Chie W.-C.; Liu J.-P.; Chen Y.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:27Z |
Prognostic factors of health care–associated bloodstream infection in adult patients ?40 years of age
|
Ma H.-Y.; Hung I.-C.; Huang Y.-H.; Chang Y.-Y.; Sheng W.-H.; JANN-TAY WANG; Chie W.-C.; Liu J.-P.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-06T01:51:58Z |
Prognostic factors of health care�Vassociated bloodstream infection in adult patients ?40 years of age
|
Ma H.-Y.; Hung I.-C.; Huang Y.-H.; Chang Y.-Y.; Sheng W.-H.; Wang J.-T.; Chie W.-C.; Liu J.-P.; YEE-CHUN CHEN |
| 國立臺灣大學 |
2014 |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu, Cho-Kai; Lee, Jen-Kuang; Chiang, Fu-Tien; Lin, Lian-Yu; Lin, Jou-Wei; Hwang, Juey-Jen; Tseng, Chuen-Den; Tsai, Chia-Ti; 林亮宇; 江福田; 吳卓鍇; 黃瑞仁; 林昭維; 蔡佳醍; 曾春典 |
| 臺大學術典藏 |
2020-12-02T11:04:37Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
CHO-KAI WU; Lee J.-K.; Chiang F.-T.; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2020-12-04T07:44:55Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.; Lee J.-K.; Chiang F.-T.; LIAN-YU LIN; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2020-12-28T12:04:03Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Tsai C.-T.; Tseng C.-D.; HWANG, JUEY-JEN; Lin J.-W.; Wu C.-K.; Lee J.-K.; Chiang F.-T.; Lin L.-Y. |
| 臺大學術典藏 |
2020-12-30T08:47:44Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Tseng C.-D.; CHIA-TI TSAI; Wu C.-K.; Lee J.-K.; Chiang F.-T.; Lin L.-Y.; Lin J.-W.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-11T04:29:40Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.;Lee J.-K.;Fu-Tien Chiang;Lin L.-Y.;Lin J.-W.;Hwang J.-J.;Tseng C.-D.;Tsai C.-T.; Wu C.-K.; Lee J.-K.; FU-TIEN CHIANG; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2022-03-07T07:05:45Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.; JEN-KUANG LEE; Chiang F.-T.; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2022-09-06T02:42:25Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.; Lee J.-K.; Chiang F.-T.; LIAN-YU LIN; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2022-09-20T06:49:21Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.; Lee J.-K.; Chiang F.-T.; Lin L.-Y.; Lin J.-W.; HWANG, JUEY-JEN; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2018-09-10T04:37:25Z |
Prognostic factors of intraspinal neurilemmoma and meningioma with severe preoperative motor deficits.
|
Chern, S.H. and Lin, S.M. and Tseng, S.H. and Tu, Y.K. and Yang, L.S. and Kao, M.C. and Hung, C.C.; Yong-Kwang Tu |
| 臺大學術典藏 |
2020-03-12T06:42:14Z |
Prognostic factors of intraspinal neurilemmoma and meningioma with severe preoperative motor deficits.
|
Chern S.H.; Lin S.M.; Tseng S.H.; YONG-KWANG TU; Yang L.S.; Kao M.C.; Hung C.C. |
| 臺大學術典藏 |
2020-03-12T08:24:53Z |
Prognostic factors of intraspinal neurilemmoma and meningioma with severe preoperative motor deficits.
|
Hung C.C.; Kao M.C.; Yang L.S.; Tu Y.K.; SHENG-HONG TSENG; Lin S.M.; Chern S.H. |
| 國立成功大學 |
2024-01-10 |
Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
|
Chen;Chen-Ya;Chang;Chao-Hsiang;Yang;Chi-Rei;Hsieh;Kun-Lin;Tsing;Wen-Hsin;Chen;Alan, I-Hsuan;Lin;Jen-Tai;Huang;Chao-Yuan;Hong;Jian-Hua;Tseng;Jen-Shu;Lin;Wun-Rong;Tsai;Yao-Chou;Wu;Shu-Yu;Shen;Cheng-Huang;Cheong;Ian-Seng;Chen;Chuan-Shu;Yang;Cheng-Kuang;Jiang;Yuan-Hong;Tsai;Chung-You;Hsueh;Thomas, Y.;Chen;Yung-Tai;Wu;Chia-Chang;Lo;Shih-Hsiu;Chiang;Bing-Juin;Lin;Yu, Wei;Lin;Po-Hung;Tai;Ta-Yao;Li;Wei-Ming;Lee;Hsiang-Ying |
| 國立臺灣大學 |
2013 |
Prognostic Factors of Metastatic or Recurrent Esophageal Squamous Cell Carcinoma in Patients Receiving Three-drug Combination Chemotherapy
|
Chen, Wei-Wu; Lin, Chia-Chi; Huang, Ta-Chen; Cheng, Ann-Lii; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 陳偉武; 鄭安理; 黃大成; 徐志宏; 葉坤輝 |
| 臺大學術典藏 |
2018-09-10T09:42:01Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen, W.-W. and Lin, C.-C. and Huang, T.-C. and Cheng, A.-L. and Yeh, K.-H. and Hsu, C.-H.; KUN-HUEI YEH |
| 臺大學術典藏 |
2020-05-25T07:35:24Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W; Chia-Chi Lin; Huang T.-C; Cheng A.-L; Yeh K.-H; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.;Lin C.-C.;Huang T.-C.;Cheng A.-L.;Kun-Huei Yeh;Hsu C.-H.; Chen W.-W.; Lin C.-C.; Huang T.-C.; Cheng A.-L.; KUN-HUEI YEH; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-10T05:34:19Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.; Lin C.-C.; Ta-Chen Huang; Cheng A.-L.; Yeh K.-H.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-18T03:23:38Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
WEI-WU CHEN; Lin C.-C.; Huang T.-C.; Cheng A.-L.; Yeh K.-H.; Hsu C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:45Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.; Lin C.-C.; Huang T.-C.; ANN-LII CHENG; Yeh K.-H.; Hsu C.-H. |
| 臺大學術典藏 |
2022-03-15T05:39:31Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
WEI-WU CHEN; Lin C.-C.; Huang T.-C.; Cheng A.-L.; Yeh K.-H.; Hsu C.-H. |
